Bio Medica Laboratories Ltd Dividend

Bio Medica Laboratories Ltd Dividend - Payout, Yield & Future Updates

Image

Bio Medica Laboratories Ltd

NSE: BioMedicaLab

Dividend Payout (-)

-

Ex-Dividend Date: NA

Bio Medica Laboratories Ltd Dividend - History

  • The Latest Trading Price of Bio Medica Laboratories Ltd is ₹ 159.65 as of 08 Sep 15:30.

swot
swot

Monitoring Bio Medica Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities.

Dividend Payout Over Time

No data available

Overview of Dividend

  • <h2><strong>Types of Dividend</strong></h2><br> <h3>Special Dividend</h3> <p>A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.</p> <br> <h3>Preferred Dividend</h3> <p>A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.</p> <br> <h3>Interim Dividend</h3> <p>Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.</p> <br> <h3>Final Dividend</h3> <p>A final dividend is issued after the year's accounts have been compiled.
  • Aside from this, the following list highlights the most prevalent sorts of dividends:</p> <br>.

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


Dividend Yield Comparison With Top Peers

* All values are in %

Image

Bio Medica Laboratories Ltd

NSE: BioMedicaLab

Share Price

₹ 159.65

-5.90 (-3.56%)

stock direction

Last updated on: Sep 08, 2026

Company Fundamentals for Bio Medica Laboratories Ltd

Dividend Payout Over Time

No data available

Net Profit Vs Dividend Per Share

SWOT Analysis

Strength

0

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Bio Medica Laboratories Ltd

Historical Market Cap of Bio Medica Laboratories Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Bio Medica Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Bio Medica Laboratories Ltd News Hub

Bio Medica Laboratories to conduct AGM

Bio Medica Laboratories announced that the 11th Annual General Meeting(AGM) of the company will be h

Read more

04 Sept 26

NSE SME Bio Medica Laboratories begins market journey on a weak note

The scrip was listed at Rs 111.20, a 20% discount to the initial public offer (IPO) price. The stock

Read more

29 May 26

Bio Medica Laboratories to conduct board meeting

Bio Medica Laboratories will hold a meeting of the Board of Directors of the Company on 22 June 2026

Read more

22 Jun 26

Bio Medica Laboratories to hold board meeting

Bio Medica Laboratories will hold a meeting of the Board of Directors of the Company on 2 September

Read more

27 Aug 26

About Bio Medica Laboratories Ltd

  • Bio Medica Laboratories Limited was originally incorporated as a private limited Company with the name of 'Bio Medica Laboratories Private Limited' vide certificate of Incorporation dated August 14, 2015, issued by Registrar of Companies, Gwalior.
  • Further, the status got converted into a Public Company & name of the Company changed from 'Bio Medica Laboratories Private Limited' to 'Bio Medica Laboratories Limited' & Registrar of Companies, CPC has issued a new Certificate of Incorporation dated October 24, 2024. Company is engaged in the of manufacturing of Pharmaceutical Parenteral Formulations.
  • It manufacture variety of products, comprising ethical drugs, generic drugs and over the-counter drugs (OTC) in the form of injectables namely Liquid Injections and Dry Powder Injections.
  • These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions